SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

HCA Inc./DE – ‘FWP’ on 6/5/19 re: HCA Inc./DE

On:  Wednesday, 6/5/19, at 9:33pm ET   ·   As of:  6/6/19   ·   Accession #:  1193125-19-166488   ·   File #:  333-226709-114

Previous ‘FWP’:  ‘FWP’ on 1/18/19   ·   Next:  ‘FWP’ on 2/12/20   ·   Latest:  ‘FWP’ on 2/21/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 6/06/19  HCA Inc./DE                       FWP                    1:41K  HCA Inc./DE                       Donnelley … Solutions/FA

Free-Writing Prospectus   —   Rule 163/433
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: FWP         Free-Writing Prospectus                             HTML     29K 


This is an HTML Document rendered as filed.  [ Alternative Formats ]



  FWP  

Filed pursuant to Rule 433

Issuer Free Writing Prospectus, dated June 5, 2019

Supplementing the Preliminary Prospectus Supplement, dated June 5, 2019

Registration No. 333-226709

HCA Inc.

$2,000,000,000 4 1/8% Senior Secured Notes due 2029 (the “2029 notes”)

$1,000,000,000 5 1/8% Senior Secured Notes due 2039 (the “2039 notes”)

$2,000,000,000 5 1/4% Senior Secured Notes due 2049 (the “2049 notes”)

(collectively, the “notes”)

Pricing Supplement

Pricing Supplement dated June 5, 2019 to HCA Inc.’s Preliminary Prospectus Supplement dated June 5, 2019. This Pricing Supplement is qualified in its entirety by reference to the Preliminary Prospectus Supplement. The information in this Pricing Supplement supplements the Preliminary Prospectus Supplement and supersedes the information in the Preliminary Prospectus Supplement to the extent it is inconsistent with the information in the Preliminary Prospectus Supplement. Financial information presented in the Preliminary Prospectus Supplement is deemed to have changed to the extent affected by changes described herein. Capitalized terms used in this Pricing Supplement but not defined have the meanings given them in the Preliminary Prospectus Supplement.

 

Terms Applicable to the 2029 notes
Issuer   HCA Inc.
Aggregate Principal Amount   $2,000,000,000
Title of Security   4 1/8% Senior Secured Notes due 2029
Maturity Date   June 15, 2029
Spread to Treasury   205 basis points
Benchmark Treasury   UST 2.375% due May 15, 2029
Benchmark Treasury Price & Yield   102-04 / 2.137%
Coupon   4 1/8%
Public Offering Price   99.497% plus accrued interest, if any, from June 12, 2019
Yield to Maturity   4.187%
Interest Payment Dates   June 15 and December 15 of each year, beginning on December 15, 2019


Record Dates   June 1 and December 1 of each year
Gross Proceeds   $1,989,940,000
Net Proceeds to Issuer before Expenses   $1,976,940,000
CUSIP/ISIN Numbers  

CUSIP: 404119 BX6

ISIN: US404119BX69

Optional Redemption  

Prior to March 15, 2029, the 2029 notes will be redeemable, at our option, at any time in whole or from time to time in part, at a redemption, or “make-whole,” price equal to the greater of:

 

(i) 100% of the aggregate principal amount of the 2029 notes to be redeemed, and

 

(ii)  an amount equal to the sum of the present value of (a) the payment on March 15, 2029 of principal of the 2029 notes to be redeemed and (b) the payment of the remaining scheduled payments through March 15, 2029 of interest on the 2029 notes to be redeemed (excluding accrued and unpaid interest to the redemption date and subject to the right of Holders on the relevant record date to receive interest due on the relevant interest payment date) discounted from their scheduled date of payment to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) using a discount rate equal to the Treasury Rate plus 35 basis points

 

plus, in each of (i) and (ii) above, accrued and unpaid interest, if any, to such redemption date.

 

On and after March 15, 2029, the 2029 notes will be redeemable, at our option, at any time in whole or from time to time in part, at a redemption price equal to 100% of the principal amount of such 2029 notes plus accrued and unpaid interest, if any, to such redemption date.

 
Terms Applicable to the 2039 notes
Issuer  

HCA Inc.

Aggregate Principal Amount  

$1,000,000,000

Title of Security  

5 1/8% Senior Secured Notes due 2039

Maturity Date  

June 15, 2039

Spread to Treasury  

255 basis points

Benchmark Treasury  

UST 3.000% due February 15, 2049

Benchmark Treasury Price & Yield  

107-05+ / 2.649%

 

2


Coupon   5 1/8%
Public Offering Price   99.086% plus accrued interest, if any, from June 12, 2019
Yield to Maturity   5.199%
Interest Payment Dates   June 15 and December 15 of each year, beginning on December 15, 2019
Record Dates   June 1 and December 1 of each year
Gross Proceeds   $990,860,000
Net Proceeds to Issuer before Expenses   $982,110,000
CUSIP/ISIN Numbers  

CUSIP: 404119 BY4

ISIN: US404119BY43

Optional Redemption  

Prior to December 15, 2038, the 2039 notes will be redeemable, at our option, at any time in whole or from time to time in part, at a redemption, or “make-whole,” price equal to the greater of:

 

(i) 100% of the aggregate principal amount of the 2039 notes to be redeemed, and

 

(ii)  an amount equal to the sum of the present value of (a) the payment on December 15, 2038 of principal of the 2039 notes to be redeemed and (b) the payment of the remaining scheduled payments through December 15, 2038 of interest on the 2039 notes to be redeemed (excluding accrued and unpaid interest to the redemption date and subject to the right of Holders on the relevant record date to receive interest due on the relevant interest payment date) discounted from their scheduled date of payment to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) using a discount rate equal to the Treasury Rate plus 40 basis points

 

plus, in each of (i) and (ii) above, accrued and unpaid interest, if any, to such redemption date.

 

On and after December 15, 2038, the 2039 notes will be redeemable, at our option, at any time in whole or from time to time in part, at a redemption price equal to 100% of the principal amount of such 2039 notes plus accrued and unpaid interest, if any, to such redemption date.

 
Terms Applicable to the 2049 notes
Issuer   HCA Inc.
Aggregate Principal Amount   $2,000,000,000
Title of Security   5 1/4% Senior Secured Notes due 2049

 

3


Maturity Date   June 15, 2049
Spread to Treasury   270 basis points
Benchmark Treasury   UST 3.000% due February 15, 2049
Benchmark Treasury Price & Yield   107-05+ / 2.649%
Coupon   5 1/4%
Public Offering Price   98.528% plus accrued interest, if any, from June 12, 2019
Yield to Maturity   5.349%
Interest Payment Dates   June 15 and December 15 of each year, beginning on December 15, 2019
Record Dates   June 1 and December 1 of each year
Gross Proceeds   $1,970,560,000
Net Proceeds to Issuer before Expenses   $1,953,060,000
CUSIP/ISIN Numbers  

CUSIP: 404119 BZ1

ISIN: US404119BZ18

Optional Redemption  

Prior to December 15, 2048, the 2049 notes will be redeemable, at our option, at any time in whole or from time to time in part, at a redemption, or “make-whole,” price equal to the greater of:

 

(i) 100% of the aggregate principal amount of the 2049 notes to be redeemed, and

 

(ii)  an amount equal to the sum of the present value of (a) the payment on December 15, 2048 of principal of the 2049 notes to be redeemed and (b) the payment of the remaining scheduled payments through December 15, 2048 of interest on the 2049 notes to be redeemed (excluding accrued and unpaid interest to the redemption date and subject to the right of Holders on the relevant record date to receive interest due on the relevant interest payment date) discounted from their scheduled date of payment to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) using a discount rate equal to the Treasury Rate plus 45 basis points

 

plus, in each of (i) and (ii) above, accrued and unpaid interest, if any, to such redemption date.

 

On and after December 15, 2048, the 2049 notes will be redeemable, at our option, at any time in whole or from time to time in part, at a redemption price equal to 100% of the principal amount of such 2049 notes plus accrued and unpaid interest, if any, to such redemption date.

 

 

4


Terms Applicable to the 2029 notes, the 2039 notes and the 2049 notes
Change of Control   Upon certain change of control events, each Holder may require the Issuer to repurchase at 101%, plus accrued and unpaid interest, if any.
Trade Date   June 5, 2019
Use of Proceeds  

We estimate that our net proceeds from this offering, after deducting underwriting discounts and estimated offering expenses, will be approximately $4,905,110,000.

 

We intend to use the net proceeds of this offering for general corporate purposes and for the redemption of all $600 million outstanding aggregate principal amount of the Issuer’s 4.25% Senior Secured Notes due 2019, all $3 billion outstanding aggregate principal amount of the Issuer’s 6.50% Senior Secured Notes due 2020 and all $1.35 billion outstanding aggregate principal amount of the Issuer’s 5.875% Senior Secured Notes due 2022.

Denominations   $2,000 and integral multiples of $1,000
Form of Offering  

SEC Registered (Registration No. 333-226709)

Joint Book-Running Managers  

BofA Securities, Inc.

Citigroup Global Markets Inc.

J.P. Morgan Securities LLC

Barclays Capital Inc.

Deutsche Bank Securities Inc.

Goldman Sachs & Co. LLC

Morgan Stanley & Co. LLC

SMBC Nikko Securities America, Inc.

Wells Fargo Securities, LLC

Co-Managers  

Mizuho Securities USA LLC

RBC Capital Markets, LLC

SunTrust Robinson Humphrey, Inc.

Capital One Securities, Inc.

Fifth Third Securities, Inc.

MUFG Securities Americas Inc.

Regions Securities LLC

Scotia Capital (USA) Inc.

Settlement Date  

June 12, 2019 (T+5)

 

We expect that delivery of the notes will be made to investors on or about June 12, 2019, which will be the fifth business day following the date of this pricing term sheet (such settlement being referred to as “T+5”). Under Rule 15c6-1 under the Exchange Act, trades in the secondary market are required to settle in two business days, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade notes prior to the delivery of the notes hereunder will be required, by virtue of the fact that the notes initially settle in T+5, to specify an alternate settlement arrangement at the time of any such trade to prevent a failed settlement. Purchasers of the notes who wish to trade the notes prior to their date of delivery hereunder should consult their advisors.

 

5


 

The issuer has filed a registration statement (including a prospectus and a related preliminary prospectus supplement) with the United States Securities and Exchange Commission (“SEC”) for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the preliminary prospectus supplement and other documents HCA Healthcare, Inc. has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, copies of the preliminary prospectus supplement and accompanying prospectus may be obtained from any of BofA Securities, Inc., NC1-004-03-43, 200 North College Street, 3rd floor, Charlotte NC 28255-0001, Attn: Prospectus Department, by telephone: (800) 294-1322 or by emailing: dg.prospectus_requests@baml.com, Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone: (800) 831-9146 or by emailing: prospectus@citi.com or J.P. Morgan Securities LLC, 383 Madison Avenue, New York, NY 10179, Attn: Investment Grade Syndicate Desk or collect at 1-212-834-4533.

This communication should be read in conjunction with the preliminary prospectus supplement and the accompanying prospectus. The information in this communication supersedes the information in the preliminary prospectus supplement and the accompanying prospectus to the extent inconsistent with the information in such preliminary prospectus supplement and the accompanying prospectus.

ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR BELOW ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM.

 

6


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘FWP’ Filing    Date    Other Filings
6/15/29
5/15/29
3/15/29
12/15/19
6/12/19
Filed as of:6/6/19
Filed on:6/5/19424B3
 List all Filings 
Top
Filing Submission 0001193125-19-166488   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 19, 5:38:00.1pm ET